@cremieuxrecueil Part of the reason that the prices are going down is it’s a real cash pay market unlike the rest of healthcare which is not a market at all.
@DrSpratticus@cpeedell positive margin rate decrease without clinical outcome changes is not an outcome that helps patients.
Why didn’t they compare with RP alone is my q?
Study examines readability of patient-facing urologic oncology trial summaries. @AviUro@UCIrvine joins @UroCancerMD@VUMCurology to discuss a readability analysis of 17,000 urologic oncology trial summaries on https://t.co/YDPoiZroyV. All readability metrics required graduate-level comprehension, far exceeding the NIH-recommended 8th-grade level. Dr. Baskin proposes using artificial intelligence to generate simplified summaries, noting ChatGPT and Gemini excel at creating accessible summaries from complex protocols at specified grade levels. #WatchNow > https://t.co/OQ49pLPvJ4
@CanesDavid 100% prefer patients w a higher base level of info. Conversation starts at higher level and we have more time to get into important details.
@FrancescoSacco1 Trials are designed the the supposed concept of equipoise where it should not be known which intervention is better or worse. It is unethical to give someone a worse treatment if you know something better is available
@FrancescoSacco1 I think it’s an interesting idea. But it truly should be just 50/50 odds based on how trials should be run. Many trials that people were excited for have come out negative
@joshuapliu How would you position yourself as a doctor to operate in this era? Maybe some sort of advertising or funnel to those searching on ChatGPT for medical care?